series-c-plus
Stage
2015
Founded
4
Investors
About
Evelo Biosciences develops oral biologic drugs based on the human microbiome to treat inflammation, cancer, and other immune-mediated diseases.
Explore Evelo Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.